172 related articles for article (PubMed ID: 19493677)
21. BRCA1 5083del19 mutant allele selectively up-regulates periostin expression in vitro and in vivo.
Quaresima B; Romeo F; Faniello MC; Di Sanzo M; Liu CG; Lavecchia A; Taccioli C; Gaudio E; Baudi F; Trapasso F; Croce CM; Cuda G; Costanzo F
Clin Cancer Res; 2008 Nov; 14(21):6797-803. PubMed ID: 18980973
[TBL] [Abstract][Full Text] [Related]
22. Marsupial BRCA1: conserved regions in mammals and the potential effect of missense changes.
Ramirez CJ; Fleming MA; Potter JD; Ostrander GK; Ostrander EA
Oncogene; 2004 Mar; 23(9):1780-8. PubMed ID: 15001988
[TBL] [Abstract][Full Text] [Related]
23. Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1.
Williams RS; Lee MS; Hau DD; Glover JN
Nat Struct Mol Biol; 2004 Jun; 11(6):519-25. PubMed ID: 15133503
[TBL] [Abstract][Full Text] [Related]
24. Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH.
Joosse SA; van Beers EH; Tielen IH; Horlings H; Peterse JL; Hoogerbrugge N; Ligtenberg MJ; Wessels LF; Axwijk P; Verhoef S; Hogervorst FB; Nederlof PM
Breast Cancer Res Treat; 2009 Aug; 116(3):479-89. PubMed ID: 18704682
[TBL] [Abstract][Full Text] [Related]
25. Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer.
Clapperton JA; Manke IA; Lowery DM; Ho T; Haire LF; Yaffe MB; Smerdon SJ
Nat Struct Mol Biol; 2004 Jun; 11(6):512-8. PubMed ID: 15133502
[TBL] [Abstract][Full Text] [Related]
26. Dominant-negative activity of a Brca1 truncation mutant: effects on proliferation, tumorigenicity in vivo, and chemosensitivity in a mouse ovarian cancer cell line.
Sylvain V; Lafarge S; Bignon YJ
Int J Oncol; 2002 Apr; 20(4):845-53. PubMed ID: 11894135
[TBL] [Abstract][Full Text] [Related]
27. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
28. Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants.
Lovelock PK; Healey S; Au W; Sum EY; Tesoriero A; Wong EM; Hinson S; Brinkworth R; Bekessy A; Diez O; Izatt L; Solomon E; Jenkins M; Renard H; Hopper J; Waring P; Tavtigian SV; Goldgar D; Lindeman GJ; Visvader JE; Couch FJ; Henderson BR; Southey M; Chenevix-Trench G; Spurdle AB; Brown MA;
J Med Genet; 2006 Jan; 43(1):74-83. PubMed ID: 15923272
[TBL] [Abstract][Full Text] [Related]
29. [Mapping of BRCT1 domain of BRCA1 with chromatin unfolding activity].
Ye QN; Hu YF; Zhong HJ; Li R; Huang CF
Sheng Wu Gong Cheng Xue Bao; 2002 Nov; 18(6):656-61. PubMed ID: 12674632
[TBL] [Abstract][Full Text] [Related]
30. MSH2 role in BRCA1-driven tumorigenesis: A preliminary study in yeast and in human tumors from BRCA1-VUS carriers.
Maresca L; Spugnesi L; Lodovichi S; Cozzani C; Naccarato AG; Tancredi M; Collavoli A; Falaschi E; Rossetti E; Aretini P; Cervelli T; Galli A; Caligo MA
Eur J Med Genet; 2015 Oct; 58(10):531-9. PubMed ID: 26381082
[TBL] [Abstract][Full Text] [Related]
31. Caspase-dependent BRCA1 cleavage facilitates chemotherapy-induced apoptosis.
Dizin E; Ray H; Suau F; Voeltzel T; Dalla Venezia N
Apoptosis; 2008 Feb; 13(2):237-46. PubMed ID: 18071904
[TBL] [Abstract][Full Text] [Related]
32. Thermal denaturation of the BRCT tandem repeat region of human tumour suppressor gene product BRCA1.
Pyrpassopoulos S; Ladopoulou A; Vlassi M; Papanikolau Y; Vorgias CE; Yannoukakos D; Nounesis G
Biophys Chem; 2005 Apr; 114(1):1-12. PubMed ID: 15792855
[TBL] [Abstract][Full Text] [Related]
33. Splicing analysis of 14 BRCA1 missense variants classifies nine variants as pathogenic.
Ahlborn LB; Dandanell M; Steffensen AY; Jønson L; Nielsen FC; Hansen TV
Breast Cancer Res Treat; 2015 Apr; 150(2):289-98. PubMed ID: 25724305
[TBL] [Abstract][Full Text] [Related]
34. RAD52 influences the effect of BRCA1/2 missense variants on homologous recombination and gene reversion in Saccharomyces cerevisiae.
Lodovichi S; Bellè F; Mercatanti A; Spugnesi L; Cozzani C; Caligo MA; Cervelli T; Galli A
FEMS Yeast Res; 2022 Jun; 22(1):. PubMed ID: 35472165
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer cell response to genistein is conditioned by BRCA1 mutations.
Privat M; Aubel C; Arnould S; Communal Y; Ferrara M; Bignon YJ
Biochem Biophys Res Commun; 2009 Feb; 379(3):785-9. PubMed ID: 19126406
[TBL] [Abstract][Full Text] [Related]
36. Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis.
Carvalho MA; Marsillac SM; Karchin R; Manoukian S; Grist S; Swaby RF; Urmenyi TP; Rondinelli E; Silva R; Gayol L; Baumbach L; Sutphen R; Pickard-Brzosowicz JL; Nathanson KL; Sali A; Goldgar D; Couch FJ; Radice P; Monteiro AN
Cancer Res; 2007 Feb; 67(4):1494-501. PubMed ID: 17308087
[TBL] [Abstract][Full Text] [Related]
37. High frequency of TP53 mutation in BRCA1 and sporadic basal-like carcinomas but not in BRCA1 luminal breast tumors.
Manié E; Vincent-Salomon A; Lehmann-Che J; Pierron G; Turpin E; Warcoin M; Gruel N; Lebigot I; Sastre-Garau X; Lidereau R; Remenieras A; Feunteun J; Delattre O; de Thé H; Stoppa-Lyonnet D; Stern MH
Cancer Res; 2009 Jan; 69(2):663-71. PubMed ID: 19147582
[TBL] [Abstract][Full Text] [Related]
38. Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach.
Tischkowitz M; Hamel N; Carvalho MA; Birrane G; Soni A; van Beers EH; Joosse SA; Wong N; Novak D; Quenneville LA; Grist SA; ; Nederlof PM; Goldgar DE; Tavtigian SV; Monteiro AN; Ladias JA; Foulkes WD
Eur J Hum Genet; 2008 Jul; 16(7):820-32. PubMed ID: 18285836
[TBL] [Abstract][Full Text] [Related]
39. Expression of an amino-terminal BRCA1 deletion mutant causes a dominant growth inhibition in MCF10A cells.
You F; Chiba N; Ishioka C; Parvin JD
Oncogene; 2004 Jul; 23(34):5792-8. PubMed ID: 15122325
[TBL] [Abstract][Full Text] [Related]
40. Yeast cells reveal the misfolding and the cellular mislocalization of the human BRCA1 protein.
Thouvenot P; Fourrière L; Dardillac E; Ben Yamin B; Lescure A; Lejour V; Heiligenstein X; Boulé JB; Romao M; Raposo-Benedetti G; Lopez BS; Nicolas A; Millot GA
J Cell Sci; 2016 Dec; 129(23):4366-4378. PubMed ID: 27802165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
